Core Points - Movano Health has received approval from the Nasdaq Hearings Panel to continue its listing on Nasdaq, contingent upon regaining compliance with specific listing rules by set deadlines [1][2] - The company must file its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, and June 30, 2025, by September 30, 2025, and maintain a bid price of at least $1.00 per share by October 30, 2025 [1][2] - Movano Health is actively working with a new auditor to complete the necessary filings and has filed a Preliminary Proxy Statement for a reverse stock split proposal to help meet the bid price requirement [2] Company Overview - Movano Health, founded in 2018, focuses on developing healthcare solutions that provide medical-grade data through wearable devices [3] - The company's flagship product, the Evie Ring, aims to deliver personalized health insights by capturing comprehensive health data [3][4] - Movano Health's proprietary technologies are designed to proactively monitor and manage health outcomes across various patient populations [4]

Core Viewpoint - Movano Health has received a notice from Nasdaq regarding non-compliance with listing rules due to the failure to file its Form 10-Q for the quarter ended March 31, 2025, which was due on May 15, 2025 [1][2]. Group 1: Compliance and Regulatory Actions - The company has 60 calendar days, until July 21, 2025, to submit a plan to regain compliance with Nasdaq's Listing Rule [2]. - If Nasdaq accepts the compliance plan, the company may have up to 180 additional days, until November 11, 2025, to file the Form 10-Q [2]. Group 2: Company Overview - Movano Health, founded in 2018, is focused on developing healthcare solutions that provide medical-grade data through wearable devices [3]. - The company's devices aim to deliver trusted health data and insights to both consumers and enterprises, enhancing health monitoring and management [4].

Core Viewpoint - Movano Health has initiated a process to explore strategic alternatives, including a potential sale or merger, to maximize shareholder value [1]. Company Overview - Movano Health, founded in 2018, is focused on developing healthcare solutions that provide medical-grade data through wearable technology [3]. - The company's devices are designed to deliver trusted health data and insights, capturing a comprehensive picture of individual health [3][4]. Strategic Actions - The Board of Directors has engaged Aquilo Partners as a financial advisor and K&L Gates LLP as legal counsel to assist in exploring strategic alternatives [1]. - There is no assurance that this process will lead to a transaction or strategic change, and the company does not plan to disclose further developments until a specific course of action is approved [2]. Financial Reporting - Movano Health has indicated that due to resource constraints, it will not timely file its quarterly report on Form 10-Q for the quarter ended March 31, 2025 [2].